Treatment of gastroesophageal reflux disease using radiofrequency ablation (Stretta procedure): An interim analysis of a randomized trial

被引：22

作者：

Kalapala R. ^{[1
]}

Shah H. ^{[1
]}

Nabi Z. ^{[1
]}

Darisetty S. ^{[1
]}

Talukdar R. ^{[1
]}

Nageshwar Reddy D. ^{[1
]}

机构：

[1] Department of Medical Gastroenterology, Asian Institute of Gastroenterology, 6-3-661, Somajiguda, Hyderabad

来源：

Indian Journal of Gastroenterology | 2017年 / 36卷 / 5期

关键词：

Clinical trial; Endotherapy; Esophagitis; Hiatus hernia; Symptom relief;

D O I：

10.1007/s12664-017-0796-7

中图分类号：

学科分类号：

摘要：

Background: Gastroesophageal reflux disease (GERD) is the most common chronic gastrointestinal disorder, affecting one third of the population worldwide. Recently, there has been a renewed interest in Stretta therapy in view of potential long-term side effects of PPIs and the durability of relief with fundoplication. Method: Prospective randomized study comparing the Stretta treatment with controls receiving PPIs. Patient (> 18 years, n = 20) with symptoms of heartburn, regurgitation, abnormal esophageal acid exposure (≥ 4%), and endoscopically confirmed esophagitis were included into the study. The primary measure was improvement in quality of life (QOL) and decrease in the frequency and severity of GERD symptoms. Results: The mean age of the patients was 39 (± 15) years and controls were 34 (± 11) years. Three months after Stretta, 80% reported improvement in QOL compared to 40% in the control group. At the end of 3 months, significant (p < 0.05) improvement in GERD symptom score for heartburn, regurgitation, chest pain, and cough compared with the control group was observed. After Stretta treatment, 60% of the patients were free of PPIs whereas there was no change in the control group. Almost 80% of the patients on Stretta treatment were satisfied with the treatment compared to 30% of the patients in the control group. Conclusion: Stretta was effective in the short-term for the management of GERD. © 2017, Indian Society of Gastroenterology.

引用

页码：337 / 342

页数：5

共 17 条

[1]

Fock K.M., Talley N., Goh K.L., Et al., Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett’s oesophagus, Gut, 65, pp. 1402-1415, (2016)

[2]

Franciosa M., Triadafilopoulos G., Mashimo H., Stretta radiofrequency treatment for GERD: a safe and effective modality, Gastroenterol Res Pract, 2013, (2013)

[3]

Jahnavi G., Patra S.R., Singh S.E.A., Study of the symptoms of gastro-esophageal reflux disease and associated risk factors among the rural school children of Veleru India, Int J Med Public Health, 3, pp. 321-324, (2013)

[4]

De Giorgi F., Palmiero M., Esposito I., Et al., Pathophysiology of gastro-oesophageal reflux disease, Acta Otorhinolaryngol Ital, 26, pp. 241-246, (2006)

[5]

Nwokediuko S.C., Current trends in the management of gastroesophageal reflux disease: a review, ISRN Gastroenterol, 2012, (2012)

[6]

Kinoshita Y., Ishihara S., Causes of, and therapeutic approaches for, proton pump inhibitor-resistant gastroesophageal reflux disease in Asia, Therap Adv Gastroenterol, 1, pp. 191-199, (2008)

[7]

Chen D., Barber C., McLoughlin P., Thavaneswaran P., Jamieson G.G., Maddern G.J., Systematic review of endoscopic treatments for gastro-oesophageal reflux disease, Br J Surg, 96, pp. 128-136, (2009)

[8]

Sheen E., Triadafilopoulos G., Adverse effects of long-term proton pump inhibitor therapy, Dig Dis Sci, 56, pp. 931-950, (2011)

[9]

Lind T., Changing surgical principles for gastro-oesophageal reflux disease—is laparoscopic fundoplication justified in the light of surgical complications?, Eur J Surg Suppl, 166, pp. 31-33, (2000)

[10]

Liang W.T., Wang Z.G., Wang F., Et al., Long-term outcomes of patients with refractory gastroesophageal reflux disease following a minimally invasive endoscopic procedure: a prospective observational study, BMC Gastroenterol, 14, (2014)

← 1 2 →